不妊症検査・治療の世界市場2021-2028

◆英語タイトル:GLOBAL INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028
◆商品コード:INK21JU020
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年6月14日
◆ページ数:245
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートは不妊症検査・治療の世界市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、性別(男性、女性)分析、エンドユーザー別(出産・外科センター、病院・研究所、精子バンク)分析、地域別分析、競争状況などを掲載したものです。
・調査範囲/手法
・エグゼクティブサマリー
・市場動向
・主要分析
・不妊症検査・治療の世界市場規模:性別(男性、女性)
・不妊症検査・治療の世界市場規模:エンドユーザー別(出産・外科センター、病院・研究所、精子バンク)
・地域別分析
・競争状況
【レポートの概要】

KEY FINDINGS
The global infertility testing & treatment market is projected to register a CAGR of 10.63% over the forecasting period of 2021 to 2028. The market growth is facilitated by key factors such as, rising stress and lifestyle disorders, increased age of conception, the surging government support, and elevating effectiveness of treatment.
MARKET INSIGHTS
Infertility is characterized as the inability to get pregnant, despite engaging in carefully timed and unprotected intercourse for 12 months. Although the cause of infertility is often difficult to determine, it may include insufficient levels of specific hormones in both women and men, in addition to problems with ovulation in women. Infertility tests typically include several special procedures, semen analysis, physical exams, and blood tests.
Aging significantly affects fertility. A woman’s ability to conceive begins to reduce after the age of 35. Furthermore, male fertility begins to decrease around the age of 40 to 45, with the reduction of sperm quality. Hence the demand for infertility testing and treatment solutions is continually rising. Age-related infertility is often perceived as an issue that can be easily resolved by assisted conception. As a result, the demand for infertility drugs rises as the rates of late pregnancies surge.
REGIONAL INSIGHTS
The global infertility testing & treatment market growth assessment includes an in-depth analysis of the Asia-Pacific, Europe, North America, and the Rest of World. The Asia-Pacific is set to grow with the highest CAGR over the forecast period, primarily owing to the rise in fertility tourism and the surging adoption of fertility procedures. Besides, relatively cheaper treatments in countries such as Singapore, Malaysia, Thailand, South Korea, and India further augment the regional market’s growth.
COMPETITIVE INSIGHTS
The industry rivalry is expected to be high in the market on account of the availability of multiple infertility testing & treatment market players. Moreover, the increasing rate of infertility rate as well as healthcare expenditures attracts potential investors to invest in the global market, thereby reinforcing the competition. Some of the key companies operating in the market are CooperSurgical, EMD Group (Merck KGaA), Fujifilm Irvine Scientific, Cook Medical Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING STRESS AND LIFESTYLE DISORDERS
3.1.2. INCREASED AGE OF CONCEPTION
3.1.3. INCREASING EFFECTIVENESS OF TREATMENTS
3.1.4. RISING GOVERNMENT SUPPORT
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF TESTING AND TREATMENT
3.2.2. INFERTILITY CONSIDERED A SOCIAL TABOO
3.2.3. POSSIBLE RISKS ASSOCIATED WITH INFERTILITY TREATMENTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. KEY BUYING CRITERIA
4.6.1. TREATMENT OPTIONS
4.6.2. QUALITY OF MEDICAL PROCEDURES
4.6.3. PRICE OF TREATMENTS
4.6.4. SHIFT TOWARDS MEDICAL TOURISM
4.6.5. REIMBURSEMENT
4.7. REGULATORY FRAMEWORK
4.8. VALUE CHAIN ANALYSIS
4.8.1. RAW MATERIAL PROCUREMENT
4.8.2. MANUFACTURING
4.8.3. SUPPLY LOGISTICS
4.8.4. DISTRIBUTION CHANNELS
4.8.5. END-USERS
5. MARKET BY GENDER
5.1. MALE
5.1.1. MALE INFERTILITY TESTING
5.1.1.1. DNA FRAGMENTATION
5.1.1.2. OXIDATIVE STRESS ANALYSIS
5.1.1.3. SPERM PENETRATION ASSAY
5.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
5.1.1.5. SPERM AGGLUTINATION
5.1.1.6. MICROSCOPIC EXAMINATION
5.1.1.7. OTHERS
5.1.2. MALE INFERTILITY TREATMENT
5.1.2.1. MEDICATION
5.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
5.2. FEMALE
5.2.1. FEMALE INFERTILITY TESTING
5.2.1.1. OVULATION TESTING
5.2.1.2. HYSTEROSALPINGOGRAPHY
5.2.1.3. LAPAROSCOPY
5.2.1.4. TRANSVAGINAL ULTRASOUND
5.2.1.5. OVARIAN RESERVE TESTING
5.2.1.6. HORMONAL LEVEL TESTING
5.2.1.7. OTHERS
5.2.2. FEMALE INFERTILITY TREATMENT
5.2.2.1. IVF WITH ICSI
5.2.2.2. IUI
5.2.2.3. IVF WITHOUT ICSI
5.2.2.4. SURROGACY
5.2.2.5. OTHERS
6. MARKET BY END-USER
6.1. FERTILITY AND SURGICAL CENTERS
6.2. HOSPITALS AND RESEARCH LABORATORIES
6.3. CRYOBANKS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. KEY GROWTH ENABLERS
7.1.2. KEY CHALLENGES
7.1.3. KEY PLAYERS
7.1.4. COUNTRY ANALYSIS
7.1.4.1. UNITED STATES
7.1.4.2. CANADA
7.2. EUROPE
7.2.1. KEY GROWTH ENABLERS
7.2.2. KEY CHALLENGES
7.2.3. KEY PLAYERS
7.2.4. COUNTRY ANALYSIS
7.2.4.1. UNITED KINGDOM
7.2.4.2. GERMANY
7.2.4.3. FRANCE
7.2.4.4. ITALY
7.2.4.5. RUSSIA
7.2.4.6. BELGIUM
7.2.4.7. POLAND
7.2.4.8. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. KEY GROWTH ENABLERS
7.3.2. KEY CHALLENGES
7.3.3. KEY PLAYERS
7.3.4. COUNTRY ANALYSIS
7.3.4.1. CHINA
7.3.4.2. JAPAN
7.3.4.3. INDIA
7.3.4.4. SOUTH KOREA
7.3.4.5. INDONESIA
7.3.4.6. THAILAND
7.3.4.7. VIETNAM
7.3.4.8. AUSTRALIA & NEW ZEALAND
7.3.4.9. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. KEY GROWTH ENABLERS
7.4.2. KEY CHALLENGES
7.4.3. KEY PLAYERS
7.4.4. REGIONAL ANALYSIS
7.4.4.1. LATIN AMERICA
7.4.4.2. MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.2. COMPANY PROFILES
8.2.1. ADORFEM
8.2.2. BANGKOK IVF CENTER
8.2.3. COOK MEDICAL INC
8.2.4. COOPER SURGICAL
8.2.5. CREATE FERTILITY CENTRE
8.2.6. EMD GROUP (MERCK KGAA)
8.2.7. ENDO INTERNATIONAL PLC
8.2.8. ESCO MEDICAL
8.2.9. FERRING PHARMACEUTICALS
8.2.10. FERTILITY FIRST
8.2.11. FUJIFILM IRVINE SCIENTIFIC
8.2.12. GENEA LTD
8.2.13. HALOTECH DNA
8.2.14. HAMILTON THRONE LTD
8.2.15. IVFTECH
8.2.16. LABOTECT GMBH
8.2.17. OLYMPUS CORPORATION
8.2.18. PROGYNY
8.2.19. THERMO FISHER SCIENTIFIC INC
8.2.20. VITROLIFE AB

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - INFERTILITY TESTING & TREATMENT
TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL MALE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL MALE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL MALE INFERTILITY TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL MALE INFERTILITY TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: PROS AND CONS OF DNA SHARING METHODS
TABLE 15: GLOBAL DNA FRAGMENTATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 16: GLOBAL DNA FRAGMENTATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 17: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 18: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 19: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 20: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 21: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS (CASA) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 22: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS (CASA) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 23: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 24: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 25: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 26: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 27: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 28: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 29: GLOBAL MALE INFERTILITY TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 30: GLOBAL MALE INFERTILITY TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 31: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 32: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 33: GLOBAL MEDICATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 34: GLOBAL MEDICATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 35: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 36: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 37: GLOBAL FEMALE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 38: GLOBAL FEMALE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 39: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 40: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 41: GLOBAL FEMALE INFERTILITY TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 42: GLOBAL FEMALE INFERTILITY TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 43: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 44: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 45: COST OF OVULATION TESTING KITS IN THE US
TABLE 46: GLOBAL OVULATION TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 47: GLOBAL OVULATION TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 48: GLOBAL HYSTEROSALPINGOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 49: GLOBAL HYSTEROSALPINGOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 50: GLOBAL LAPAROSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 51: GLOBAL LAPAROSCOPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 52: GLOBAL TRANSVAGINAL ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 53: GLOBAL TRANSVAGINAL ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 54: GLOBAL OVARIAN RESERVE TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 55: GLOBAL OVARIAN RESERVE TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 56: GLOBAL HORMONAL LEVEL TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 57: GLOBAL HORMONAL LEVEL TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 58: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 59: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 60: GLOBAL FEMALE INFERTILITY TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 61: GLOBAL FEMALE INFERTILITY TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 62: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 63: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 64: GLOBAL IVF WITH ICSI MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 65: GLOBAL IVF WITH ICSI MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 66: GLOBAL IUI MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 67: GLOBAL IUI MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 68: GLOBAL IVF WITHOUT ICSI MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 69: GLOBAL IVF WITHOUT ICSI MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 70: GLOBAL SURROGACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 71: GLOBAL SURROGACY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 72: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 73: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 74: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 75: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 76: GLOBAL FERTILITY AND SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 77: GLOBAL FERTILITY AND SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 78: GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 79: GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 80: GLOBAL CRYOBANKS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 81: GLOBAL CRYOBANKS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 82: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 83: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 84: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 85: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 86: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 87: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 88: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 89: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 90: REST OF WORLD INFERTILITY TESTING & TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 91: REST OF WORLD INFERTILITY TESTING & TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 92: LIST OF MERGERS & ACQUISITIONS
TABLE 93: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 94: LIST OF PARTNERSHIPS & AGREEMENTS


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
FIGURE 8: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020
FIGURE 10: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 12: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)
FIGURE 13: CAUSES OF SPERM DNA FRAGMENTATION
FIGURE 14: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 22: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 25: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020
FIGURE 26: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 27: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020
FIGURE 28: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)
FIGURE 29: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)
FIGURE 30: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 31: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)
FIGURE 32: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 33: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)
FIGURE 34: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 35: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 36: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020
FIGURE 37: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)
FIGURE 38: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)
FIGURE 39: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)
FIGURE 40: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)
FIGURE 41: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 42: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 43: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 44: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 45: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)
FIGURE 46: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 47: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 48: CANADA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 49: EUROPE INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 50: UNITED KINGDOM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 51: GERMANY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 52: FRANCE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 53: ITALY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 54: RUSSIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 55: BELGIUM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 56: POLAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 57: REST OF EUROPE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 58: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 59: CHINA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 60: JAPAN INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 61: INDIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 62: SOUTH KOREA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 63: INDONESIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 64: THAILAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 65: VIETNAM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 66: AUSTRALIA & NEW ZEALAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 67: REST OF ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION
FIGURE 68: REST OF WORLD INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 69: LATIN AMERICA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 70: MIDDLE EAST & AFRICA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[不妊症検査・治療の世界市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆